About Linda Herrera Santos, MD, PhD

Dr. Linda Herrera Santos serves as the Director of the MGH Hispanic Psychiatry Clinic. She is an Instructor in Psychiatry at Harvard Medical School and an attending psychiatrist in the Psychiatry Consultation Service at MGH. She teaches and supervises MGH/McLean Psychiatry residents and is the co-director of the Sociocultural Didactics Series. Dr. Herrera Santos obtained her medical degree from Texas A&M Health Science Center. She completed the Adult Psychiatry Residency Training at MGH/McLean, followed by the MGH Consultation-Liaison Psychiatry Fellowship. As a trainee, Dr. Herrera Santos was awarded the APA SAMHSA Minority Fellowship, which funded a project addressing mental health in underserved populations. She founded the Hispanic Psychiatry Clinic, under the mentorship of Katia Canenguez, PhD, EdM, and secured funding for its pilot through an MGH Collaboration Catalyst Grant and a Research Grant through the MGB Centers of Expertise. She was awarded the MGH CDI Clinician-Teacher Development Award. Dr. Herrera Santos’ clinical and research interests are focused on delivering mental health services to Hispanic populations. She is committed to expanding initiatives promoting an inclusive healthcare community and delivering excellent, compassionate, and culturally humble care.

Departments, Centers, & Programs:

Clinical Interests:



Medical Education

  • MD, Texas A&M Health Science Center College of Medicine
  • Residency, Massachusetts General Hospital

American Board Certifications

  • Psychiatry and Neurology, American Board of Psychiatry and Neurology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • Espi Forcen, E., Velez Florez, M. C., Bido Medina, R., Zambrano, J., Hermina Perez, J., Morfin Rodriguez, A., Herrera Santos, L. Deconstructing Cultural Aspects of Mental Health Care in Hispanic/Latinx People. Psychiatric Annals. DOI: 10.3928/00485713-20230215-02. In press

    Masaki CO, Ogbu-Nwobodo L, Santos LH, Faisel LB, Lewis A, Soumare A, Quijije N, Ross RA. A Virtual Summer Research and Mentorship Program for Underrepresented in Medicine (URiM) Medical Students in Psychiatry. Acad Psychiatry. 2022 Aug;46(4):537-539. doi: 10.1007/s40596-022-01631-2. Epub 2022 Apr 12. PMID: 35414163; PMCID: PMC9004450.

    Herrera, L.J., Brand, S., Santos, A., Nohara, L.L., Harrison, J., Norcross, N.R., Thompson, S., Smith, V., Lema, C., Varela-Ramirez, A. and Gilbert, I.H., 2016. Validation of N- myristoyltransferase as potential chemotherapeutic target in mammal-dwelling stages of Trypanosoma cruzi. PLoS Neglected Tropical Diseases, 10(4), p.e0004540.

    Vasquez, M.A., Iniguez, E., Das, U., Beverley, S.M., Herrera, L.J., Dimmock, J.R. and Maldonado, R.A., 2015. Evaluation of a, ?-unsaturated ketones as antileishmanial agents. Antimicrobial agents and chemotherapy, 59(6), pp.3598-3601.

    Martinez, A., Carreon, T., Iniguez, E., Anzello_, A., Sa?nchez, A., Tyan, M., SaFler, A., Herrera, L., Maldonado, R.A. and Sa?nchez-Delgado, R.A., 2012. Searching for new chemotherapies for tropical diseases: Ruthenium?clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells. Journal of medicinal chemistry, 55(8), pp.3867-3877.

Reviews: Comments and Ratings